potential short press Games picked up momentum in 2021 and continued into 2022, with new retailers looking for the next big step.
Here’s a look at the top five short squeeze candidates based on that Feint Short squeeze leaderboard.
Greenwich Life Sciences: Clinical-stage biopharmaceutical company Greenwich Life Sciences GLSI then climbed back up to the top of Fintel’s short squeeze leaderboard third place last week. The data showed that 28.5% of the float is short, up from the 27.5% reported last week. The cost of borrowing for shares is 11.1%, down slightly from the 11.6% reported last week.
Aerovate Therapeutics: Clinical-stage biopharmaceutical company Aerovate Therapeutics AVTE Jumped 18 spots on the leaderboard to second place for the week. The data showed 31.5% float short, the highest rate of the top five short squeeze candidates. The cost of borrowing stocks is 6.8%.
Heart Beam Inc: Heart attack detection technology company HeartBeam Inc HIT made the biggest jump on the leaderboard, moving up 968 positions to third place. The data shows that 11.7% of the float is empty. While the short percentage was the lowest of the top five short squeeze candidates, borrowing costs for investors are likely to skyrocket. Fintel reported borrowing costs up 397.8%, one of the week’s highest.
Minerva Neuroscience: Clinical-stage biopharmaceutical company Minerva Neurosciences Inc NERVE Fourth on the short squeeze leaderboard, consistent with last week’s ranking. The data showed that 12.2% of the float is empty, down from the 23.2% reported last week. The cost of credit for stocks is 79.7%. The company previously topped the short squeeze leaderboard in September.
Virgin Orbit Holdings: Satellite launch and space technology company Virgin Orbit Holdings Inc prep Jumped 38 places to fifth on the Short Squeeze Leaderboard. The data showed 18.1% of the float short and borrowing costs of 95.8%. The company which went public via the SPAC merger has shares currently near a 52-week low of $2.50…
